Activated T cell content in allografts is associated with higher incidences of aGVHD and cGVHD.
Allograft activated NK cell content is associated with a lower incidence of aGVHD.
In AML/MDS patients, early activated T and NKT cell content is associated with lower relapse.
Presence of HLA-Bw4-80Ile+ genotype is associated with lower relapse-free survival.
Unrelated donors were associated with a higher incidence of aGVHD and lower relapse.